Episode Details

What happens when you connect Trump’s new drug-buying website, TrumpRx, with the ongoing conversation about cannabis rescheduling? The answer could reshape both healthcare and the cannabis industry.TrumpRx is designed as a government-backed platform to let Americans access prescription drugs at lower prices, with Pfizer as its launch partner. On its own, that’s a big deal. But when you add the potential for cannabis rescheduling — moving it from Schedule I to Schedule III — the dots begin to connect in new and important ways.If cannabis is recognized as a federally legitimate medicine, it could eventually find a place on TrumpRx or similar programs. That opens the door for Big Pharma to step in — companies like Pfizer, Merck, or Johnson & Johnson — and bring their scale, research, and lobbying power into cannabinoids. For patients, this could mean easier access and lower costs. For the cannabis sector, it could mean legitimacy and new investor attention.But there are cautions. Big Pharma’s entry could bring pricing pressure, increased competition, and the risk that cannabis access shifts away from dispensaries and toward a system controlled by traditional pharmaceutical channels. Smaller cannabis operators need to prepare now.TDR Cannabis in 5, presented by Dutchie, walks through how TrumpRx, cannabis rescheduling, and Big Pharma could collide to reshape healthcare, industry strategy, and investor outlook.The cannabis industry stands at a crossroads. Adaptation will decide who thrives and who gets left behind.#TrumpRx #CannabisRescheduling #BigPharma #CannabisStocks #ScheduleIII #DonaldTrump #Pfizer #MarijuanaReclassification #CannabisNews #TrumpMarijuana #USNews #LegalizationOfMarijuanaWant to see last week's recap?   • Weekly Recap: Supreme Court Showdown Over ...  Want to see more Cannabis Reform videos?   • Senator Ties Cannabis Rescheduling to Bank...     • Trump Endorses Cannabis in Truth Social Vi...     • Congress Faces Backlash Over Hemp THC Ban ...     • Is Biased Polling Shaping Cannabis Reform?...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:

Listen Now